A Technology That Deserves More Clinical Attention

The breast imaging space has seen meaningful technological evolution over the past two decades — digital mammography, tomosynthesis, contrast-enhanced mammography, abbreviated MRI protocols. Each advance has addressed specific limitations of the modalities that preceded it. Each has also introduced new considerations around workflow, cost, patient experience, and clinical positioning.

Dedicated breast CT is the next inflection point in this evolution, and it's one that's now far enough along in its US clinical presence to warrant serious attention from radiologists, breast imaging specialists, and imaging center directors who are thinking about their technology roadmaps.

This isn't a speculative discussion of an emerging prototype. The Koning Vera system is a commercially available, FDA-cleared platform with a growing clinical evidence base and an established presence in US academic and private practice imaging settings. The question isn't whether this technology exists — it's whether your practice understands it well enough to make informed decisions about its role in your clinical program.

The Clinical Rationale for Dedicated Breast CT

What volumetric imaging solves

The fundamental limitation of projection imaging — whether standard mammography or tomosynthesis — is that it produces a two-dimensional representation of three-dimensional anatomy. Tomosynthesis improved on conventional mammography by generating pseudo-three-dimensional reconstructions from a limited arc of projection images, which significantly reduced the masking effects of overlapping tissue. But it remains a limited-angle acquisition with inherent constraints on spatial resolution in the depth dimension.

Dedicated breast CT acquires a true isotropic volumetric dataset. There is no preferred imaging plane — the reconstructed volume can be interrogated in any plane at any depth with equal spatial resolution in all directions. The clinical implications of this are meaningful: lesion characterization, margin evaluation, and spatial relationship assessment all benefit from genuine three-dimensional interrogation rather than pseudo-three-dimensional reconstruction.

The diagnostic positioning

Understanding where Koning Vera 3D breast CT fits in the diagnostic algorithm requires being precise about its current clinical indications and evidence base. The strongest current applications are in the diagnostic rather than screening context: evaluation of known or suspected abnormalities, preoperative staging and planning, assessment of patients with implants or significant architectural distortion, and problem-solving in cases where conventional imaging findings are inconclusive.

The screening application is the subject of ongoing clinical investigation. The performance characteristics — sensitivity, specificity, recall rates — are being studied in comparison to and in combination with established screening modalities. Staying current with this evolving evidence base is important for anyone positioning this technology within a clinical program.

Patient Experience as a Clinical Variable

Why it's not a soft metric

Clinicians sometimes treat patient experience as a secondary consideration relative to image quality and diagnostic performance. In breast imaging, that framing misses something important: screening participation is the point. An imaging modality that produces excellent results but that patients avoid using delivers poor population-level outcomes.

The discomfort associated with conventional mammography is a well-documented barrier to screening compliance in the US. Studies have consistently shown that pain and discomfort during mammography are associated with delayed rescreening, non-attendance, and intent not to return. In a screening program where annual participation is the goal, anything that reduces that compliance has downstream clinical consequences.

No compression breast imaging removes one of the primary experiential barriers to breast imaging participation. The prone positioning, natural tissue pendant geometry, and absence of mechanical compression represent a categorically different patient experience from conventional mammography. For practices that track patient-reported experience and screening compliance metrics, this distinction is worth quantifying in your own patient population.

Workflow and Integration Considerations

What implementation actually involves

For imaging center directors and practice administrators evaluating dedicated breast CT, the workflow considerations are real and worth addressing directly. Scan acquisition time is fast — a complete bilateral volumetric acquisition takes under a minute. Reading time is different from mammography — a volumetric dataset requires scrolling through cross-sectional images in multiple planes, which takes longer than reviewing a standard four-view mammogram.

This reading workflow difference has implications for radiologist time allocation, scheduling models, and productivity metrics. Practices that have implemented dedicated breast CT successfully have typically adapted their reading room workflows rather than trying to fit a volumetric modality into a projection imaging workflow model.

Integration with PACS and RIS systems requires attention to the volumetric data format and the viewer capabilities needed for efficient interpretation. Most modern enterprise imaging systems accommodate this, but verifying your infrastructure's compatibility before implementation is standard due diligence.

Positioning within a multimodality program

The most useful frame for thinking about dedicated breast CT in a breast imaging program is complementary positioning rather than competitive replacement. It addresses specific clinical problems — density-related masking, diagnostic problem-solving, implant evaluation, preoperative assessment — where its three-dimensional volumetric imaging characteristics offer genuine advantages over projection modalities.

The 3d breast ct dataset also offers capabilities that projection imaging cannot: lesion volume measurement, three-dimensional margin characterization, spatial relationship to chest wall or nipple, and the ability to interrogate the entire breast volume without repositioning or additional views. These capabilities have value in specific clinical contexts that justify dedicated technology.

The Dense Breast Clinical Problem

A growing referral opportunity

With breast density notification now mandated in all 50 US states, the population of women who know they have dense breasts and are asking questions about supplemental screening has grown substantially. Many of these women are not well served by available supplemental options: whole-breast ultrasound has significant operator and reader variability; MRI is expensive, requires contrast, and is typically reserved for high-risk populations; contrast-enhanced mammography is valuable but involves iodinated contrast and an exposure pattern different from screening.

Dedicated breast CT offers a supplemental imaging pathway that addresses the density-related masking problem through three-dimensional volumetric imaging without the logistical and cost burden of MRI. For practices building out their dense breast referral program, this is a technology worth understanding in detail.

What the evidence says and where gaps remain

Being clear-eyed about the evidence base is important. The diagnostic performance of dedicated breast CT in dense breast populations is an active area of investigation with encouraging early results. The comparative evidence against tomosynthesis in this specific population is still developing. Practices implementing this technology in a dense breast supplemental screening context should do so with clear protocols for patient selection, appropriate informed consent around the evolving evidence, and a commitment to contributing to the clinical knowledge base through outcomes tracking.

Building a Rational Technology Roadmap

The imaging center that will be positioned well five years from now is the one making thoughtful technology decisions now — not chasing every new system, but also not ignoring meaningful advances until competitors are already two years ahead.

Dedicated breast CT, and the Koning Vera platform specifically, represents a clinically meaningful advance with a clear and growing body of evidence, established FDA clearance, and real patient experience advantages. Understanding it well enough to make an informed positioning decision — whether that's early adoption, planned adoption, or monitored observation — is the work of a well-managed imaging program.

The technology exists. The clinical indications are real. The patient experience advantages are documented. What remains is the institutional decision about how and when it fits in your program.

Ready to evaluate dedicated breast CT for your imaging program? Connect with a Koning representative, review the current clinical evidence, and talk to programs that have already implemented the Vera system. Informed technology decisions start with accurate information.